Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pasithea Therapeutics Corp (KTTA)

Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,776
  • Shares Outstanding, K 1,042
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,960 K
  • 60-Month Beta 0.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.33
Trade KTTA with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.70 +6.68%
on 03/22/24
9.25 -22.70%
on 04/08/24
+0.18 (+2.53%)
since 03/15/24
3-Month
5.70 +25.33%
on 02/07/24
9.25 -22.70%
on 04/08/24
-0.36 (-4.79%)
since 01/12/24
52-Week
5.25 +36.09%
on 12/20/23
17.40 -58.91%
on 12/11/23
-0.65 (-8.36%)
since 04/14/23

Most Recent Stories

More News
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029

EQNX::TICKER_START (NASDAQ:KTTA),(NASDAQ:SWTX),(NASDAQ:DAWN),(NASDAQ:VSTM),(NASDAQ:KNTE) EQNX::TICKER_END

KTTA : 7.15 (-4.16%)
DAWN : 13.85 (+0.58%)
SWTX : 42.51 (-0.56%)
VSTM : 11.07 (-2.04%)
KNTE : 2.65 (-0.38%)
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029

/PRNewswire/ -- Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue....

KTTA : 7.15 (-4.16%)
SWTX : 42.51 (-0.56%)
DAWN : 13.85 (+0.58%)
VSTM : 11.07 (-2.04%)
KNTE : 2.65 (-0.38%)
Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the “Investor Group” or “we”), who are collectively the largest...

KTTA : 7.15 (-4.16%)
Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the “Investor Group” or “we”), who are collectively the largest...

KTTA : 7.15 (-4.16%)
Investor Group Comments on Pasithea Therapeutics’ Seemingly Defensive and Ill-Timed Acquisition of AlloMek Therapeutics

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the "Investor Group" or "we"), who are collectively the largest stockholder...

KTTA : 7.15 (-4.16%)
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028

Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...

KTTA : 7.15 (-4.16%)
AZN : 68.73 (-0.29%)
LOGC : 2.07 (+0.49%)
CRDF : 5.28 (-5.88%)
SWTX : 42.51 (-0.56%)
DAWN : 13.85 (+0.58%)
Investor Group Sends Letter to Pasithea Therapeutics’ Board of Directors

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the "Investor Group" or "we"), who are collectively the largest stockholder...

KTTA : 7.15 (-4.16%)
Investor Group Successful in Request to Call Special Meeting of Stockholders of Pasithea Therapeutics

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the "Investor Group" or "we"), who together are one of the largest stockholders...

KTTA : 7.15 (-4.16%)
Investor Group Urges Stockholders of Pasithea Therapeutics to Vote to Call Special Meeting

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the "Investor Group" or "we"), who together are one of the largest stockholders...

KTTA : 7.15 (-4.16%)
Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029

Palm Beach, FL –– August 11, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination,...

KTTA : 7.15 (-4.16%)
BNTX : 87.89 (+1.63%)
AMLX : 2.07 (-1.43%)
SIGA : 8.88 (+0.79%)
MRNA : 103.86 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pasithea Therapeutics Corp. is a biotechnology company. It focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Pasithea Therapeutics Corp. is based in MIAMI BEACH, Fla.

See More

Key Turning Points

3rd Resistance Point 7.48
2nd Resistance Point 7.42
1st Resistance Point 7.28
Last Price 7.15
1st Support Level 7.08
2nd Support Level 7.02
3rd Support Level 6.88

See More

52-Week High 17.40
Fibonacci 61.8% 12.76
Fibonacci 50% 11.33
Fibonacci 38.2% 9.89
Last Price 7.15
52-Week Low 5.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar